Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus type b conjugate vaccine or as pentavalent vaccine

被引:14
作者
Begue, P [1 ]
Stagnara, J [1 ]
VieLeSage, F [1 ]
Bernard, JC [1 ]
Xerri, B [1 ]
Abitol, V [1 ]
机构
[1] SMITHKLINE BEECHAM LABS,NANTERRE,FRANCE
关键词
pertussis; acellular; vaccine; booster;
D O I
10.1097/00006454-199708000-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The high reactogenicity of whole cell pertussis vaccines discourages their use in children. While acellular pertussis vaccines are less reactogenic, their use in diphtheria-tetanus-acellular pertussis (DTPa)-based combinations with Haemophilus influenzae type b conjugate vaccine (Hib) and poliomyelitis vaccines must be evaluated. Objectives. To assess the immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (DTPa-IPV) given concurrently with Hib as a mixed vaccine or as separate injections, in comparison with a whole cell pertussis vaccine (DTPw-IPV-Hib). Materials and methods. This open, randomized, controlled study involved 145 healthy children ages 15 to 24 months. Immunogenicity was evaluated for all vaccine antigens, and reactogenicity was assessed with diary cards. Results. Serum antibody responses to all vaccine antigens was at least as good as that observed with the pentavalent whole cell vaccine. DTPa-IPV was well-tolerated and less reactogenic than the DTPw-IPV vaccine. Administration of DTPa-IPV and Hib vaccine either separately or mixed did not alter the immunogenicity or reactogenicity profiles. Conclusion. DTPa-IPV vaccine, either separately or mixed with Hib vaccine, was at least as immunogenic and less reactogenic than the DTPw-Hib vaccine. Mixing DTPa-IPV and Hib vaccines did not alter the safety profile when compared with separate injections of both vaccines, A mixed DTPa-IPV-Hib Vaccine can be recommended for routine use as a booster dose in primed children.
引用
收藏
页码:787 / 794
页数:8
相关论文
共 40 条
  • [21] Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine
    Eskola, J
    Olander, RM
    Hovi, T
    Litmanen, L
    Peltola, S
    Kayhty, H
    [J]. LANCET, 1996, 348 (9043) : 1688 - 1692
  • [22] PERTUSSIS-VACCINE AND INJURY TO THE BRAIN
    GOLDEN, GS
    [J]. JOURNAL OF PEDIATRICS, 1990, 116 (06) : 854 - 861
  • [23] ACELLULAR PERTUSSIS-VACCINE IN ADULTS - ADVERSE REACTIONS AND IMMUNE-RESPONSE
    GRANSTROM, M
    THOREN, M
    BLENNOW, M
    TIRU, M
    SATO, Y
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (01) : 18 - 21
  • [24] A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis
    Greco, D
    Salmaso, S
    Mastrantonio, P
    Giuliano, M
    Tozzi, AE
    Anemona, A
    Atti, MLCD
    Giammanco, A
    Panei, P
    Blackwelder, WC
    Klein, DL
    Wassilak, SGF
    Stefanelli, P
    Bottone, M
    Sofia, T
    Luzi, S
    Bellomi, G
    Cobianchi, F
    Canganella, G
    Meduri, F
    Scuderi, G
    Chiarini, A
    Maggio, M
    Taormina, S
    Genovese, M
    Moiraghi, A
    Barale, A
    DiTommaso, S
    Malaspina, S
    Vasile, E
    Ferraro, P
    DalLago, P
    DeMarzi, L
    Robino, L
    Giraldo, E
    Coppola, N
    Materassi, P
    Castellani, GT
    Basso, F
    Barbuti, S
    Quarto, M
    Lopalco, P
    DOrazio, P
    Sanguedolce, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) : 341 - 348
  • [25] PERMANENT BRAIN-DAMAGE AND PERTUSSIS VACCINATION - IS THE END OF THE SAGA IN SIGHT
    GRIFFITH, AH
    [J]. VACCINE, 1989, 7 (03) : 199 - 210
  • [26] Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France
    Grimprel, E
    Begue, P
    Anjak, I
    Njamkepo, E
    Francois, P
    Guiso, N
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (01) : 93 - 97
  • [27] A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine
    Gustafsson, L
    Hallander, HO
    Olin, P
    Reizenstein, E
    Storsaeter, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) : 349 - 355
  • [28] ACELLULAR PERTUSSIS DIPHTHERIA-TETANUS-PERTUSSIS VACCINE CONTAINING SEPARATELY PURIFIED PERTUSSIS TOXOID, FILAMENTOUS HEMAGGLUTININ AND 69 KDA OUTER-MEMBRANE PROTEIN AS A BOOSTER IN CHILDREN
    KANRA, G
    CEYHAN, M
    VANDEVOORDE, D
    BOGAERTS, H
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (06) : 478 - 483
  • [29] STATISTICAL CONSIDERATIONS IN THE QUANTITATION OF SERUM IMMUNOGLOBULIN LEVELS USING THE ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA)
    KARPINSKI, KF
    HAYWARD, S
    TRYPHONAS, H
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 103 (02) : 189 - 194
  • [30] Karsenty JY, 1990, B EPIDEMIOL HEBD, V19, P81